Compare AA & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AA | ALGN |
|---|---|---|
| Founded | 1888 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aluminum | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7B | 12.7B |
| IPO Year | 2016 | 2000 |
| Metric | AA | ALGN |
|---|---|---|
| Price | $54.04 | $178.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | $67.20 | ★ $199.82 |
| AVG Volume (30 Days) | ★ 4.7M | 935.9K |
| Earning Date | 04-16-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.64% | N/A |
| EPS Growth | ★ 1580.77 | 0.53 |
| EPS | ★ 1.60 | 1.57 |
| Revenue | ★ $12,831,000,000.00 | $387,126,000.00 |
| Revenue This Year | $16.05 | $5.78 |
| Revenue Next Year | N/A | $4.62 |
| P/E Ratio | ★ $33.07 | $111.91 |
| Revenue Growth | 7.87 | ★ 23.95 |
| 52 Week Low | $28.11 | $122.00 |
| 52 Week High | $84.38 | $208.31 |
| Indicator | AA | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 32.12 | 52.38 |
| Support Level | $35.17 | $164.49 |
| Resistance Level | $67.60 | $180.17 |
| Average True Range (ATR) | 2.95 | 7.02 |
| MACD | -1.95 | 0.06 |
| Stochastic Oscillator | 10.98 | 49.49 |
Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is one of the world's largest bauxite miners and alumina refiners by production volume, but sits outside the top-10 aluminum producers, a list dominated by Chinese companies. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.